tirzepatide vs semaglutide chemical structure Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review 👉 Which treatment is right

If you cant keep fluids down for 24 hours, seek immediate medical attention

This has shifted the conversation somewhat, and off-label longer-term use is becoming more common in obesity medicine

The exact mechanism isnt fully understood, but its likely related to electrolyte changes from reduced food intake, dehydration, or the medications direct effects on muscle tissue

FDA Approval Status: Wegovy is FDA-approved specifically for weight management, while Tirzepatide (as Mounjaro) was initially approved for type 2 diabetes

A formulation patent for a known drug in a new delivery system, for example, might be grantable in the United States if it produces unexpected efficacy improvements, but would face significant inventive step challenges in Colombia or Ecuador absent very strong efficacy data demonstrating a non-obvious improvement over the prior art

February 18, 2025, and March 19, 2025: Enforcement discretion periods ended